{"doi":"10.1016/j.ijid.2024.107260","title":"Randomised immunogenicity trial comparing 2019-2020 recombinant and egg-based influenza vaccines among frequently vaccinated healthcare personnel in Israel","abstract":"OBJECTIVES: Trivalent inactivated influenza vaccine effectiveness was low in a prospective cohort of healthcare personnel (HCP) in Israel from 2016 to 2019. We conducted a randomised immunogenicity trial of quadrivalent recombinant influenza vaccine (RIV4) and standard-dose inactivated influenza vaccine (IIV4) among frequently and infrequently vaccinated previous cohort participants. METHODS: From October 2019 to January 2020, we enrolled and randomly allocated HCP from two Israeli hospitals to receive IIV4 or RIV4. Hemagglutination inhibition (HAI) antibody titres against 2019-2020 vaccine reference influenza viruses were compared between vaccine groups using geometric mean titre (GMT) ratios from sera collected one-month post-vaccination and by frequency of vaccination in the past 5 years (>2 vs ≤2). RESULTS: Among 415 HCP, the GMT ratio comparing RIV4 to IIV4 was 2.0 (95% confidence interval [CI] 1.7-2.7) for A(H1N1)pdm09, 1.6 (95% CI: 1.3-1.9) for A(H3N2), 1.8 (95% CI: 1.4-2.2) for B(Yamagata), and 1.1 (95% CI: 0.9-1.4) for B(Victoria). Similarly, RIV4 elicited higher HAI titres than IIV4 against all 2019-2020 vaccine reference viruses except B(Victoria) among infrequently and frequently vaccinated HCP (lower bound of GMT ratio 95% CIs ≥1.0). CONCLUSION: RIV4 had improved immunogenicity for influenza vaccine strains among both infrequent and frequent vaccinees compared to standard-dose IIV4. CLINICAL TRIALS REGISTRATION: NCT04523324.","journal":"International Journal of Infectious Diseases","year":2024,"id":447639,"datarank":0.3343038376140965,"base_score":1.9459101490553132,"endowment":1.9459101490553132,"self_citation_contribution":0.29188652235829704,"citation_network_contribution":0.04241731525579945,"self_endowment_contribution":0.29188652235829704,"citer_contribution":0.04241731525579945,"corpus_percentile":null,"corpus_rank":null,"citation_count":6,"citer_count":4,"citers_with_citation_signal":2,"citers_with_endowment":2,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9583,"is_data_producer":true,"deposit_databanks":{"ClinicalTrials.gov":["NCT04523324"]},"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2024-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1266254,"name":"Alon Peretz","orcid":null,"position":1,"is_corresponding":false},{"id":1265726,"name":"David Greenberg","orcid":"0000-0002-8746-1410","position":2,"is_corresponding":false},{"id":1265727,"name":"Avital Hirsch","orcid":"0000-0002-3393-9853","position":3,"is_corresponding":false},{"id":226888,"name":"Emily T. Martin","orcid":"0000-0002-5771-8895","position":4,"is_corresponding":false},{"id":7177,"name":"Min Z. Levine","orcid":"0000-0002-3197-1649","position":5,"is_corresponding":false},{"id":1086614,"name":"Laura Edwards","orcid":"0000-0002-3984-6017","position":6,"is_corresponding":false},{"id":1266255,"name":"Sarah Radke","orcid":null,"position":7,"is_corresponding":false},{"id":226886,"name":"Adam S. Lauring","orcid":"0000-0003-2906-8335","position":8,"is_corresponding":false},{"id":249371,"name":"Jill M. Ferdinands","orcid":"0000-0002-4008-0653","position":9,"is_corresponding":false},{"id":552586,"name":"Chao Zhang","orcid":"0000-0003-3009-598X","position":10,"is_corresponding":false},{"id":452887,"name":"Young M. Yoo","orcid":"0000-0002-0845-2293","position":11,"is_corresponding":false},{"id":1265728,"name":"Jacob Dreiher","orcid":"0000-0002-2216-5215","position":12,"is_corresponding":false},{"id":826514,"name":"Gabriella Newes‐Adeyi","orcid":"0000-0002-4411-0370","position":13,"is_corresponding":false},{"id":7186,"name":"Eduardo Azziz‐Baumgartner","orcid":"0000-0001-8038-0530","position":14,"is_corresponding":false},{"id":7176,"name":"Alicia M. Fry","orcid":"0000-0002-3208-9308","position":15,"is_corresponding":false},{"id":231053,"name":"Arnold S. Monto","orcid":"0000-0003-3018-435X","position":16,"is_corresponding":false},{"id":41068,"name":"Ran D. Balicer","orcid":"0000-0002-7783-6362","position":17,"is_corresponding":false},{"id":7183,"name":"Mark G. Thompson","orcid":"0000-0003-0046-3147","position":18,"is_corresponding":false},{"id":227057,"name":"Mark A. Katz","orcid":"0000-0002-5532-7276","position":19,"is_corresponding":false},{"id":667685,"name":"Ashley Fowlkes","orcid":"0000-0002-0620-6451","position":0,"is_corresponding":true}],"reference_count":36,"raw_metadata":null,"created_at":"2026-07-19T02:02:03.354708Z","pmid":"39395753","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}